Prof. Joe Cardaci
Nuclear Medicine Physician, MBBS, FRACP, AANNMS
For patients/carers
For doctors
Nuclear Medicine Physician, MBBS, FRACP, AANNMS
Biography
Clinical interests in prostate cancer and neuroendocrine tumours (NETs).
Prof Cardaci is a Nuclear Medicine Physician with a long-standing interest in theranostics. He was involved in the early development of SIRT therapy for liver cancer. He has been involved in multiple international research trials advancing the field of radionuclide therapy in advanced malignancies. Dr Cardaci's clinical interests are advanced prostate cancer, neuroendocrine tumours (NETs), and liver cancer.
Prof Cardaci also practices as a General Medicine Physician, overseeing a busy medical department at Hollywood Private Hospital, Perth. He is actively engaged in medical student and Basic Physician training, and is Adjunct Associate Professor at University of Notre Dame
More information
- Novel treatments for hard-to-treat cancers and radionuclide therapies.
- Royal Australasian College of Physicians (RACP)
- Fellow of the Australasian Association of Nuclear Medicine (FAANMS)
- Kesavan, M., Turner, J. H., Meyrick, D., Yeo, S., Cardaci, G., & Lenzo, N. P. (2018). Salvage radiopeptide therapy of advanced castrate-resistant prostate cancer with lutetium-177-labelled prostate-specific membrane antigen: Efficacy and safety in routine practice. Cancer Biotherapy & Radiopharmaceuticals, 33(7), 274–281. https://doi.org/10.1089/cbr.2018.2487
- Van Hazel, G., Blackwell, A., Anderson, J., Price, D., Moroz, P., Bower, G., Cardaci, G., & Gray, B. (2004). Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. Journal of Surgical Oncology, 88(2), 78–85. https://doi.org/10.1002/jso.20141